AptarGroup, Inc. (ATR)
NYSE: ATR · Real-Time Price · USD
155.52
+2.20 (1.43%)
At close: May 12, 2025, 4:00 PM
155.52
0.00 (0.00%)
After-hours: May 12, 2025, 7:00 PM EDT
AptarGroup Revenue
AptarGroup had revenue of $887.31M in the quarter ending March 31, 2025, a decrease of -3.07%. This brings the company's revenue in the last twelve months to $3.55B, up 0.34% year-over-year. In the year 2024, AptarGroup had annual revenue of $3.58B with 2.74% growth.
Revenue (ttm)
$3.55B
Revenue Growth
+0.34%
P/S Ratio
2.90
Revenue / Employee
$263,315
Employees
13,500
Market Cap
10.27B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.58B | 95.44M | 2.74% |
Dec 31, 2023 | 3.49B | 165.20M | 4.97% |
Dec 31, 2022 | 3.32B | 95.03M | 2.94% |
Dec 31, 2021 | 3.23B | 297.88M | 10.17% |
Dec 31, 2020 | 2.93B | 69.61M | 2.43% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
ATR News
- 10 days ago - AptarGroup, Inc. (ATR) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Aptar Reports First Quarter 2025 Results - Business Wire
- 25 days ago - Aptar Declares Quarterly Dividend - Business Wire
- 27 days ago - Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year - Business Wire
- 4 weeks ago - AptarGroup: Strong Pharma And Closure Growth To Offset Beauty Headwinds - Seeking Alpha
- 7 weeks ago - Aptar Recognized with Prestigious 'A' Score on the CDP Climate Change Assessment - Business Wire
- 3 months ago - AptarGroup, Inc. (ATR) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Aptar Reports Fourth Quarter and Annual 2024 Results - Business Wire